Access the updated page using the API Locator.   Our Custom Search for Pharma News…

FDA Approval Activities for this Drug… Rescriptor (delavirdine) Tablet, 100 & 200mg Agouron 20-705/S-009 3/14/02 3/29/02 Rescriptor (delavirdine mesylate) Tablet, Agouron NDA 20-705/S-008 5/16/01 7/24/03 5/16/01 Rescriptor (delavirdine mesylate) Tablet, 200mg Pharmacia & Upjohn Company 20-705/S-003 7/14/99 7/28/99 7/28/99 Rescriptor Indication:For the treatment of HIV-1 infection in combination with appropriate antiretroviral agents. | Rescriptor (delavirdine mesylate) Oral Tablets, Pfizer, Labeling Revision View updates.                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | VOIP © 2012 Betterchem.com